Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SOPHIA ANTIPOLIS, France, May 30, 2014 (GLOBE NEWSWIRE) -- Nicox S.A. (NYSE Euronext Paris: COX) today issued a revised version of the press release dated May 28, 2014, to correct the number of...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} CORRECTED RELEASE - Nicox: Santen...
-
SOPHIA ANTIPOLIS, France, May 28, 2014 (GLOBE NEWSWIRE) -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, today announces that its wholly-owned Italian subsidiary...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Nicox: Santen grants Eupharmed extension...
-
BOSTON, MA--(Marketwired - May 27, 2014) - In addition to refractive cataract and LASIK procedures, Dr. Helen R. Moreira, an ophthalmologist in Boston, performs a variety of surgeries at The...
-
NEW YORK, May 27, 2014 (GLOBE NEWSWIRE) -- DepYmed Inc., a joint venture of Ohr Pharmaceutical, Inc. (Nasdaq:OHRP) and Cold Spring Harbor Laboratory, today announced the validation of Trodusquemine...
-
TAMPA, FL--(Marketwired - May 22, 2014) - Nextech, a leading provider of specialty-focused healthcare technology solutions for physician practices, is...
-
REGULATED INFORMATION ThromboGenics Business Update Corporate In February, the Board of Directors of ThromboGenics decided to explore strategic options for the Company. This decision is...
-
24-Month Data Confirms Results of 12-Month Pilot Study of 2RT Non-Thermal, Non-Damaging Method of Action Supports Potential Use of 2RT Laser to Slow Progression of Age-Related Macular Degeneration...
-
Novartis acquires exclusive ex-US rights to Fovista from Ophthotech; upfront payment of USD 200 million plus potential future recruitment and other milestone payments; additionally Ophthotech to...